Description
Reglisam Pharmacodynamics
It has anti-inflammatory, moderate expectorant effect, stimulates the function of the adrenal cortex
Indications
As an expectorant in the treatment of
Respiratory diseases with sputum difficult to separate (including mild bronchial asthma).
Eczema, allergic dermatitis, Addison’s disease (diencephalic-pituitary forms, both alone and in combination with
with adrenocorticotropic hormone), asthenic conditions and hypotonic syndrome, hypofunction of the adrenal cortex after long-term therapy with glucocorticosteroids, including the prevention of withdrawal syndrome during discontinuation of treatment with glucocorticosteroids or reduction of their dosage (as part of complex therapy).
Contraindications
Hypersensitivity to the drug components, severe organic lesions of the heart and parenchymatous organs, pregnancy, breast-feeding, under 10 years of age.
Dosage and administration method
- Inside, 30 minutes before a meal or 30 minutes after a meal. Adults and children over 10 years – 1-2 tablets 2 times a day. In more severe cases, a single dose of the drug is 2 tablets 3-6 times a day. Duration of treatment is from 2 weeks to 6 months. The possibility of repeated courses, drug doses and duration of treatment are determined by the doctor.
